checkAd
    Startseite > Aktien > Astria Therapeutics > Nachrichten
    Astria Therapeutics Aktie
    9,4700
     
    USD
    +5,11 %
    +0,4600 USD
    Letzter Kurs 01.06.24 Nasdaq
    9,4900
     
    USD
    400 STK
    Geldkurs 31.05.24
    9,5000
     
    USD
    2.600 STK
    Briefkurs 31.05.24
    ISIN: US04635X1028 · WKN: A3C2EY · SYM: ATXS · USA

    Neueste Nachrichten

    Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
    30.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
    24.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
    23.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
    09.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
    08.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    02.05.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
    09.04.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.04.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
    25.03.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.03.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
    04.03.24 · Business Wire (engl.) · Astria Therapeutics
    Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
    20.02.24 · Business Wire (engl.) · Astria Therapeutics